IBDEI1NK ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26390,1,4,0)
 ;;=4^E11.41
 ;;^UTILITY(U,$J,358.3,26390,2)
 ;;=^5002645
 ;;^UTILITY(U,$J,358.3,26391,0)
 ;;=E11.42^^107^1241^13
 ;;^UTILITY(U,$J,358.3,26391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26391,1,3,0)
 ;;=3^DM Type 2 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,26391,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,26391,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,26392,0)
 ;;=E11.43^^107^1241^2
 ;;^UTILITY(U,$J,358.3,26392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26392,1,3,0)
 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,26392,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,26392,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,26393,0)
 ;;=E11.44^^107^1241^1
 ;;^UTILITY(U,$J,358.3,26393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26393,1,3,0)
 ;;=3^DM Type 2 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,26393,1,4,0)
 ;;=4^E11.44
 ;;^UTILITY(U,$J,358.3,26393,2)
 ;;=^5002648
 ;;^UTILITY(U,$J,358.3,26394,0)
 ;;=E11.49^^107^1241^8
 ;;^UTILITY(U,$J,358.3,26394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26394,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,26394,1,4,0)
 ;;=4^E11.49
 ;;^UTILITY(U,$J,358.3,26394,2)
 ;;=^5002649
 ;;^UTILITY(U,$J,358.3,26395,0)
 ;;=E11.59^^107^1241^25
 ;;^UTILITY(U,$J,358.3,26395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26395,1,3,0)
 ;;=3^DM Type 2 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,26395,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,26395,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,26396,0)
 ;;=E11.610^^107^1241^9
 ;;^UTILITY(U,$J,358.3,26396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26396,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,26396,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,26396,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,26397,0)
 ;;=E11.618^^107^1241^26
 ;;^UTILITY(U,$J,358.3,26397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26397,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,26397,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,26397,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,26398,0)
 ;;=E11.621^^107^1241^16
 ;;^UTILITY(U,$J,358.3,26398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26398,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,26398,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,26398,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,26399,0)
 ;;=E11.622^^107^1241^31
 ;;^UTILITY(U,$J,358.3,26399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26399,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,26399,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,26399,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,26400,0)
 ;;=E11.628^^107^1241^30
 ;;^UTILITY(U,$J,358.3,26400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26400,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Compl
 ;;^UTILITY(U,$J,358.3,26400,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,26400,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,26401,0)
 ;;=E11.630^^107^1241^33
 ;;^UTILITY(U,$J,358.3,26401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26401,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,26401,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,26401,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,26402,0)
 ;;=E11.638^^107^1241^29
 ;;^UTILITY(U,$J,358.3,26402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26402,1,3,0)
 ;;=3^DM Type 2 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,26402,1,4,0)
 ;;=4^E11.638
